JAN 25, 2022 7:00 AM PST

Lung Cancer Vaccine Goes on Trial

WRITTEN BY: Tara Fernandes

Vaccines have been a hot topic in the headlines—blueprints that train the immune system to target a disease-causing pathogen without producing an actual illness. COVID-19 vaccines, for example, present immune cells with the spike protein of the coronavirus. After this stimulation, vaccines prime memory T cells and antibody-producing B cells to effectively fight off the virus, should they encounter it in the future.

Vaccines aren’t just used for fending off bacteria and viruses. An emerging field of medicine is exploring ways of using vaccines to prevent or treat cancer. Cancer vaccines use cells, genetically-engineered viruses, proteins, or genetic material to manipulate the immune system to better recognize and destroy cancer cells. 

This innovative approach to battling cancer with the power of the immune system falls under the umbrella of immunotherapy and has been hailed as one of the most promising scientific breakthroughs. In spite of cancer vaccines’ transformative potential, scientists still face several challenges in making safe, effective therapies. For instance, some cancer patients have weakened immune systems (as a result of chemotherapy or other factors), so vaccines may not trigger a potent immune response. In addition, finding the right molecular cancer targets to direct immune cells to can be tricky.

Recently, cancer researchers in the UK have kicked off a clinical trial testing the safety and effectiveness of a new experimental cancer vaccine against the most common type of lung cancer. Around 85 percent of lung cancer patients have non-small-cell lung cancer, a malignancy of the epithelial cells in the lungs. This cancer is notoriously resistant to conventional chemotherapy interventions, which has spurred studies around alternative strategies to treat patients.

Accordingly, in collaboration with industry partners Vaccitech Oncology, Oxford researchers developed VTP-600, a therapeutic cancer vaccine powered by an engineered chimpanzee adenovirus.

Professor Fiona Blackhall, the researcher leading the trial, said there is an urgent need to develop better treatments to save the lives of patients with non-small-cell lung cancer.

“The VTP-600 immunotherapeutic vaccine is a cutting edge technology which targets a patient’s immune system to tackle cancer cells,” said Blackhall, adding that the trial will be conducted across ten specialist hospitals across the UK.

The full VTP-600 treatment regime consists of three shots, one prime, and two booster shots. 

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
FEB 17, 2022
Immunology
A Post-vaccination Workout Boosts Immune Responses
FEB 17, 2022
A Post-vaccination Workout Boosts Immune Responses
  A workout after getting a vaccine for influenza or COVID-19 may provide additional immune protection, says a new ...
MAR 07, 2022
Immunology
Newly Discovered T Cell Subset is Linked to Autoimmune Disease
MAR 07, 2022
Newly Discovered T Cell Subset is Linked to Autoimmune Disease
T cells are on the front lines of the immune system, and can work against infections and cancer cells. But the activity ...
MAR 07, 2022
Neuroscience
Drinking Milk Aggravates Multiple Sclerosis
MAR 07, 2022
Drinking Milk Aggravates Multiple Sclerosis
A protein found in cow’s milk can trigger inflammation in the surrounding areas of neurons in mice, and may have i ...
MAR 29, 2022
Immunology
A Master Regulator That Helps Power Immune Cells on the Attack
MAR 29, 2022
A Master Regulator That Helps Power Immune Cells on the Attack
When pathogens infect cells, the immune system has to launch a counterattack. Researchers have now learned more about ho ...
APR 25, 2022
Microbiology
How a Serious Infection Can Cause Mood Disorders
APR 25, 2022
How a Serious Infection Can Cause Mood Disorders
When a pathogen invades the body, the immune system has to mount a response, which involves inflammation. But inflammati ...
MAY 02, 2022
Clinical & Molecular DX
A Lyme Disease Vaccine Could be Available Soon
MAY 02, 2022
A Lyme Disease Vaccine Could be Available Soon
There is currently no vaccine available to prevent Lyme disease, a tick-borne illness prevalent across the United States ...
Loading Comments...